HIGHLIGHTS Bulletin No. 2024–32 OF THIS ISSUE August 5, 2024
ADMINISTRATIVE
Internal Revenue Bulletin 2024-32 · 2026-10-03 edition · updated 2026-10-04 · United States
TD 10003, page 342. This document contains final regulations relating to the excise tax imposed on certain sales by manufacturers, producers, or importers of designated drugs. Specifically, the final regulations set forth procedural provisions relating to how taxpayers must report liability for such tax. The final regulations also except such tax from semimonthly deposit requirements. The final regulations affect manufacturers, producers, or importers of designated drugs dispensed, furnished, or administered to individuals under the terms of Medicare during certain statutory periods.
Get a plain-English answer with a citation back to this text.
Ask AI about this code